Karel Petrak D Phil*.
Matrx Pharmaceuticals, Inc, USA.
*Corresponding Author: Karel Petrak D Phil, Matrx Pharmaceuticals, Inc, USA.
Received: December 09, 2019; Published: January 07, 2020
Artificial Intelligence (AI) could make a major contribution to the development of disease-targeted drug delivery by elucidating what drives diseases at the molecular level, and in particular what unique molecular structures are involved that are not shared by non-disease cells. To this end, AI will need to acquire the manner of processing information in human-thinking terms such as perception, abstraction and memories, apply critical analysis of the information and then remember and recall outcomes as and when needed to synthesize a new, more complex whole. Ultimately, it will need to have the capacity to generate new knowledge and know-how.
Keywords: Molecular Structures; Progression
Citation: Karel Petrak D Phil. “A Challenge to Artificial Intelligence: Find Molecular Structures Uniquely and Functionally Connected to the Initiation and Progression of Diseases”.Acta Scientific Cancer Biology 4.2 (2020): 01-04.
Copyright: © 2020 Karel Petrak D Phil. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.